– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May 28, 2024 –
– CABA-201 exhibited anticipated profile of CAR T cell
OpenAI has appointed retired U.S. Army General Paul M. Nakasone to its Board of Directors. Nakasone, a cybersecurity expert, will bring his expertise to the Board's Safety and Security Committee.